Literature DB >> 20062609

Severe anorexia nervosa, co-occurring major depressive disorder and electroconvulsive therapy as maintenance treatment: a case report.

Outi Poutanen1, Kaija Huuhka, Kaisa Perko.   

Abstract

INTRODUCTION: It is difficult to treat patients who, in addition to having severe anorexia nervosa, also have severe symptoms of major depressive disorder and a tendency for impulsive acting out behaviour. Our case report considers the feasibility of maintenance electroconvulsive therapy in such complicated cases. CASE
PRESENTATION: This is a case report of a woman with anorexia nervosa and co-morbid severe major depressive disorder who was treated with electroconvulsive therapy as a maintenance treatment. The maintenance electroconvulsive therapy was conducted without immediate complications. It had a positive effect on the patient's depressive symptoms and lability and her general wellbeing, although some cognitive deficits were observed.
CONCLUSION: The maintenance electroconvulsive therapy seemed to support recovery in a case of refractory anorexia nervosa and a tendency for labile mood. The symptoms of co-occurring major depressive disorder were partly relieved and maintenance electroconvulsive therapy had some positive effect on weight gain.

Entities:  

Year:  2009        PMID: 20062609      PMCID: PMC2804009          DOI: 10.1186/1757-1626-2-9362

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


  14 in total

1.  An inventory for measuring depression.

Authors:  A T BECK; C H WARD; M MENDELSON; J MOCK; J ERBAUGH
Journal:  Arch Gen Psychiatry       Date:  1961-06

2.  Cognitive status of psychiatric patients under maintenance electroconvulsive therapy: a one-year longitudinal study.

Authors:  Lorena Rami; Miquel Bernardo; Teresa Boget; José Ferrer; Maria J Portella; Jose A Gil-Verona; Manel Salamero
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2004       Impact factor: 2.198

Review 3.  Treatment of patients with eating disorders,third edition. American Psychiatric Association.

Authors: 
Journal:  Am J Psychiatry       Date:  2006-07       Impact factor: 18.112

4.  Psychiatric comorbidities of female inpatients with eating disorders.

Authors:  Barton J Blinder; Edward J Cumella; Visant A Sanathara
Journal:  Psychosom Med       Date:  2006 May-Jun       Impact factor: 4.312

5.  The cognitive effects of electroconvulsive therapy in community settings.

Authors:  Harold A Sackeim; Joan Prudic; Rice Fuller; John Keilp; Philip W Lavori; Mark Olfson
Journal:  Neuropsychopharmacology       Date:  2006-08-23       Impact factor: 7.853

6.  The use of electroconvulsive therapy in patients with intractable anorexia nervosa.

Authors:  J M Ferguson
Journal:  Int J Eat Disord       Date:  1993-03       Impact factor: 4.861

7.  Anorexia nervosa with comorbid psychosis and borderline mental retardation: a case report.

Authors:  Maureen Dymek; Daniel le Grange
Journal:  Int J Eat Disord       Date:  2002-05       Impact factor: 4.861

8.  Anorexia nervosa in an elderly woman.

Authors:  R Hill; C Haslett; S Kumar
Journal:  Aust N Z J Psychiatry       Date:  2001-04       Impact factor: 5.744

9.  A new depression scale designed to be sensitive to change.

Authors:  S A Montgomery; M Asberg
Journal:  Br J Psychiatry       Date:  1979-04       Impact factor: 9.319

10.  Neuropsychological effects and attitudes in patients following electroconvulsive therapy.

Authors:  Miriam Feliu; Christopher L Edwards; Shiv Sudhakar; Camela McDougald; Renee Raynor; Stephanie Johnson; Goldie Byrd; Keith Whitfield; Charles Jonassaint; Heather Romero; Lekisha Edwards; Chante' Wellington; LaBarron K Hill; James Sollers; Patrick E Logue
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

View more
  1 in total

Review 1.  Brain Stimulation in Eating Disorders: State of the Art and Future Perspectives.

Authors:  Philibert Duriez; Rami Bou Khalil; Yara Chamoun; Redwan Maatoug; Robertas Strumila; Maude Seneque; Philip Gorwood; Philippe Courtet; Sébastien Guillaume
Journal:  J Clin Med       Date:  2020-07-23       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.